Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2018

May 11, 2018

SELL
$16.09 - $23.07 $160,900 - $230,700
-10,000 Closed
0 $0
Q4 2017

Feb 26, 2018

BUY
$13.36 - $20.73 $132,264 - $205,227
9,900 Added 9900.0%
10,000 $190,000
Q4 2017

Feb 13, 2018

BUY
$13.36 - $20.73 $1,336 - $2,073
100
100 $9,000

Others Institutions Holding SPPI

# of Institutions
1
Shares Held
115K
Call Options Held
0
Put Options Held
0

About SPECTRUM PHARMACEUTICALS INC


  • Ticker SPPI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 188,164,000
  • Description
  • Spectrum Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes oncology and hematology drug products. The company's products under development include Eflapegrastim, a novel long-acting granulocyte colony-stimulating factor for chemotherapy-induced neutropenia; Poziotinib, a novel irreversible tyrosine kinase inhibitor ...
More about SPPI
Track This Portfolio

Track Sg3 Management, LLC Portfolio

Follow Sg3 Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg3 Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg3 Management, LLC with notifications on news.